Exton, PA, August 16, 2016 --(PR.com
)-- KinderPharm is pleased to announce that it will hold a Grand Opening event and Ribbon-Cutting ceremony for its new office at 100 Arrandale Blvd., Exton, Pennsylvania on Friday, August 26th from 1 p.m. to 3 p.m. The event will feature a ribbon-cutting ceremony at 1 p.m., food and refreshments, and industry networking.
Welcoming KinderPharm to the new office will be Congressman Ryan Costello, State Senator Andrew Dinniman, and the President of Pennsylvania Bio, Christopher Molineaux. Speaking and assisting in the ribbon-cutting ceremony include Congressman Costello, Senator Dinniman, CEO Molineaux, and KinderPharm executives.
KinderPharm, LLC, is an expert pediatric drug development organization focusing exclusively on co-developing pediatric medicines with our pharmaceutical and biotechnology industry partners. Our out-sourced “Pediatric Center of Excellence” model is a unique resource of pediatricians, pharmacometricians, regulatory affairs, drug safety and formulation scientists that develop pediatric drugs through all stages of pre-clinical and clinical development. At this new location, KinderPharm will offer a multitude of services including pediatric formulation development, juvenile toxicology study design, pediatric PK/PD modeling and dose extrapolation, clinical trial simulation, clinical trial management and expertize in pediatric drug regulatory affairs.
“Pennsylvania and Chester County are an ideal location to further our company’s growth,” said Dr. Martin Graham, President and CEO of KinderPharm. “The grand opening event is a celebration of everyone’s hard work, including PA Bio, our investors, our industry partners, and the employees of KinderPharm. I see this new office as the next step in expanding our innovative out-sourced “Pediatric Center of Excellence” model to a global scale.”
KinderPharm, LLC, based in Exton, PA, is an expert pediatric co-development partner, focusing exclusively on pediatric drug development. Our out-sourced “Pediatric Center of Excellence” model is a unique resource of pediatricians, pharmacometricians, regulatory, drug safety and formulation scientists that develop pediatric drugs through all stages of development. Our seasoned teams bring expertise and insight to help effectively navigate the complex pediatric regulatory environments in the US and Europe. We are dedicated to one single goal namely “Bringing better medicines to children”. To learn more information about KinderPharm visit www.kinderpharm.com
About Pennsylvania Bio
Pennsylvania Bio’s mission is to ensure Pennsylvania is the United States hub for the life sciences by creating a business and public policy environment which fosters life sciences growth and success. Pennsylvania Bio was founded 26 years ago by a group of Biotech CEOs. Today it’s grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania. PA Bio delivers two valuable services – public policy clout, and strategic connections that can advance you and your organization. Our public policy work in both Harrisburg and Washington ensures that all of our members are heard by those who make legislative decisions. PA Bio provides members with unparalleled networking opportunities to facilitate strategic connections. Our array of both large and small events throughout the year, along with our partnership with BioNJ and the strategic group buying program, ensure that our members stay connected. To learn more information about PA Bio visit www.pabio.org.